Sign in
Active, not recruitingNo phase

Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss

Key facts

Who runs it
Zhongshan Hospital Xiamen University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
197 people, planned
Started
1 Jun 2025
Ended
1 Jun 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Vitamin D Supplementation+ standard treatment
  • standard treatment
Record updated
4 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Clinical diagnosis of Idiopathic Sudden Sensorineural Hearing Loss First-time unilateral occurrence Illness duration ≤14 days No prior treatment

Who cannot take part

  • Middle ear lesions, inner ear malformations, or retrocochlear lesion Age <18 years, pregnant or lactating women History of ear surgery or familial hereditary deafness With osteoporosis, osteochondrosis, rickets and other systemic serious systemic diseases Those who refuse to be enrolled

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Clinical Trial Protocol: Investigating the Therapeutic Efficacy of Vitamin D in ISSNHL。Core Research Questions Can vitamin D supplementation improve the prognosis of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)? What potential medical issues might arise during vitamin D administration? Study Design

Read full original descriptionShow less

A controlled trial comparing:

Intervention group: Vitamin D supplementation + standard care Control group: Standard care alone Participant Procedures

Baseline assessment:

Venous blood draw (2 mL) for 25(OH)D level measurement. intervention phase:Daily vitamin D supplementation for 1 month

Endpoint evaluation (1-month follow-up):

Repeat audiometric testing (pure-tone audiometry). Post-treatment 25(OH)D concentration analysis.

The 2 groups in the trial

  • Vitamin D SupplementationTreatment being tested

    Participants receive Vitamin D3 (dose: 800 IU/day, orally, for 4 weeks)

    Treatment: Vitamin D Supplementation+ standard treatment

  • Standard CareOther group

    Standard treatment

    Treatment: standard treatment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mechanism and Clinical Application of Vitamin D in Influencing the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
Record updated
4 July 2025